Fundz

Elkedonia raised EUR 11M in Seed funding, led by Kurma Partners and others, to advance treatments for depression and neuropsychiatric disorders.

PRIVATEJun 11, 2025

Amount Raised

€11 Million

Round Type

Seed

StrasbourgBiotechnologyHealth CareTherapeutics

Investors

We Life Sciences (Wallonie Entreprendre)ArgobioAngelini VenturesCarma FundCapital Grand EstSambrinvestKurma PartnersFrench Tech Seed Fund

Description

Elkedonia, based in Strasbourg, France, closed EUR 11M in Seed funding. The round was led by Kurma Partners, WE Life Sciences, and the French Tech Seed fund. The funds will help advance therapeutics for treatment-resistant depression and other neuropsychiatric disorders. Elkedonia aims to improve mental health treatments using a precision medicine approach.

Quick answer

Elkedonia raised €11 Million in a Seed round, dated June 11, 2025. Investors: We Life Sciences (Wallonie Entreprendre), Argobio, Angelini Ventures, Carma Fund, Capital Grand Est, Sambrinvest, Kurma Partners and French Tech Seed Fund. Elkedonia is based in Strasbourg, Grand Est, France.

How much did Elkedonia raise?
Elkedonia raised €11 Million in a Seed round on June 11, 2025.
Who invested in Elkedonia?
We Life Sciences (Wallonie Entreprendre), Argobio, Angelini Ventures, Carma Fund, Capital Grand Est, Sambrinvest, Kurma Partners and French Tech Seed Fund are named as investors in this round.
What does Elkedonia do?
Elkedonia is a Strasbourg, France-based company leveraging a new neuroplastogen approach to develop therapeutic agents to treat depression and other neuropsychiatric conditions.
Where is Elkedonia based and how big is it?
Elkedonia is based in Strasbourg, Grand Est, France. Fundz records about 2 employees.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Elkedonia that raised within 45 days of this round, from Fundz verified event records.

  • Canton Strategic Holdings, Inc. raised $1.2M (Seed) on July 25, 2025.
  • Pharvaris raised $201M (Funding Round) on July 25, 2025.
  • Targepeutics raised an undisclosed amount (Corporate Round) on July 24, 2025.
  • Canton Strategic Holdings, Inc. raised $1.7M (Seed) on July 23, 2025.
  • DiaMedica Therapeutics raised $30M on July 23, 2025.
  • Lapix Therapeutics raised $2.2M (Seed) on July 21, 2025.

Who to call at Elkedonia, and when

A new round usually means Elkedonia is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Elkedonia raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Elkedonia, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Elkedonia. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Elkedonia

Location

Strasbourg, Grand Est, France

About

Elkedonia is a Strasbourg, France-based company leveraging a new neuroplastogen approach to develop therapeutic agents to treat depression and other neuropsychiatric conditions. The company is dedicated to improving the treatment of mental health disorders by introducing an antidepressant approach that leverages precision medicine. Their lead discovery program targets the inhibition of the intracellular Elk1 protein to address the needs of treatment-resistant depression (TRD).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Elkedonia raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Elkedonia's next move

See what Strategic adds

Elkedonia raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.